Fairgrieve, Feldschreiber, Howells and Pilgerstorfer, ‘Products in a Pandemic: Liability for Medical Products and the Fight against COVID-19’

ABSTRACT
A multitude of medical products are being developed and produced as part of efforts to tackle COVID-19. They are varied in nature and range from test kits to tracing apps, protective equipment, ventilators, medicines and, of course, vaccines. The design, testing and manufacture of many of these products differs from production in normal times due to the urgency of the situation and the rapid increase in demand created by the pandemic. This article considers the legal issues arising as a result of the production of emergency products, particularly from a products liability perspective. To what extent do existing concepts under the European Product Liability Directive, such as defect, causation and the various defences, permit the pandemic to be taken into account when a Court is considering issues of liability? What is the impact on liability of the modified regulatory regime? In light of that discussion, the case for alternative responses is examined from a comparative and European perspective, including the issue of Government indemnities for the manufacturers of products, legal exemptions from liability and alternative no-fault compensation schemes.

Duncan Fairgrieve, Peter Feldschreiber, Geraint Howells and Marcus Pilgerstorfer, Products in a Pandemic: Liability for Medical Products and the Fight against COVID-19, European Journal of Risk Regulation, volume 11, issue 3, September 2020, pp 565-603.

Leave a Reply